AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8296814 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity transcutaneous electrical nerve stimulation
Number of subjects: 12
Study 8296814 — intervention group
Group type: COMPARATOR
Intervention: Oral naproxen (500 mg)
Number of subjects: 12
Study 2690225 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined modality treatment with 2x (COPP + ABVD) followed by 20 or 40 Gy EF radiation (HD1 protocol)
Number of subjects: 226
Study 2690225 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with 3x (COPP + ABVD) followed by consolidation therapy (20 Gy IF or further chemotherapy) or salvage therapy (40Gy or 4x CEVD chemotherapy) (HD3 protocol)
Number of subjects: 226
Study 999494 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (20-40 mg every 4 hours, increased to 280-2320 mg per day)
Number of subjects: 6
Study 999494 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexpropranolol (900 mg daily for 5 days)
Number of subjects: 6
Study 999494 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in 3 cases under double blind conditions)
Number of subjects: 6
Study 29442231 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth Aware of Mental Health (YAM) programme
Number of subjects: 0
Study 29442231 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 26723137 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Individual and Group Intervention (CIGI)
Number of subjects: 99
Study 26723137 — intervention group
Group type: COMPARATOR
Intervention: Treatment-As-Usual (TAU)
Number of subjects: 99
Study 24486835 — intervention group
Group type: EXPERIMENTAL
Intervention: N2O (60% inspired Nitrous oxide)
Number of subjects: 601
Study 24486835 — intervention group
Group type: COMPARATOR
Intervention: AIR (40% oxygen)
Number of subjects: 601
Study 22476175 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-expandable metal stents (SEMS)
Number of subjects: 31
Study 22476175 — intervention group
Group type: COMPARATOR
Intervention: Plastic multistent
Number of subjects: 31
Study 21313952 — intervention group
Group type: EXPERIMENTAL
Intervention: In-group faces recognition
Number of subjects: 0
Study 21313952 — intervention group
Group type: COMPARATOR
Intervention: Out-group faces recognition
Number of subjects: 0
Study 17921365 — intervention group
Group type: EXPERIMENTAL
Intervention: Price increase of low-energy-density (LED) foods
Number of subjects: 0
Study 17921365 — intervention group
Group type: EXPERIMENTAL
Intervention: Price increase of high-energy-density (HED) foods
Number of subjects: 0
Study 17921365 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal BMI interaction with price increase of HED foods
Number of subjects: 0
Study 17921365 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal BMI interaction with price increase of LED foods
Number of subjects: 0
Study 16118152 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography (US) of the common extensor tendon
Number of subjects: 22
Study 16118152 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography (US) findings
Number of subjects: 22
Study 12384358 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin-nonsusceptible pneumococcus isolated from blood or cerebrospinal fluid
Number of subjects: 100
Study 12384358 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal isolates resistant to penicillin (MIC, > or =2.0 micro g/ml)
Number of subjects: 100
Study 12384358 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolation of penicillin-nonsusceptible pneumococcus in children
Number of subjects: 100
Study 12384358 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolation of penicillin-nonsusceptible pneumococcus in adults with meningitis
Number of subjects: 100
Study 12384358 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilocus sequence typing of invasive penicillin-resistant pneumococcus isolates
Number of subjects: 100
Study 12384358 — intervention group
Group type: EXPERIMENTAL
Intervention: Serotypes of penicillin-nonsusceptible pneumococci
Number of subjects: 100
Study 10063913 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth subsalicylate (30 ml)
Number of subjects: 10
Study 10063913 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethyl alcohol (60 ml, 40% v/v)
Number of subjects: 10
Study 10063913 — intervention group
Group type: COMPARATOR
Intervention: Bismuth subsalicylate (30 ml) pretreatment with ethyl alcohol
Number of subjects: 10
Study 10063913 — intervention group
Group type: COMPARATOR
Intervention: Placebo pretreatment with ethyl alcohol
Number of subjects: 10
Study 9063856 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy extracorporeal shock wave therapy (ESWT)
Number of subjects: 30
Study 9063856 — intervention group
Group type: COMPARATOR
Intervention: Simulated ESWT (placebo)
Number of subjects: 30
Study 2043531 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine
Number of subjects: 60
Study 2043531 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 60
Study 7180830 — intervention group
Group type: EXPERIMENTAL
Intervention: Dibromodulcitol, adriamycin, and tamoxifen (DAT)
Number of subjects: 32
Study 7180830 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin-C and tamoxifen (MT)
Number of subjects: 32
Study 30658774 — intervention group
Group type: EXPERIMENTAL
Intervention: Counterforce bracing
Number of subjects: 31
Study 30658774 — intervention group
Group type: COMPARATOR
Intervention: Placebo bracing
Number of subjects: 31
Study 28371689 — intervention group
Group type: EXPERIMENTAL
Intervention: Take-home self-administered sublingual buprenorphine-naloxone weekly (mean dose, 22.7±5.7mg)
Number of subjects: 50
Study 28371689 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (no clinical intervention)
Number of subjects: 50
Study 28371689 — intervention group
Group type: EXPERIMENTAL
Intervention: Take-home self-administered sublingual buprenorphine-naloxone weekly
Number of subjects: 50
Study 26437830 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g freeze-dried wild blueberry (WBB) powder
Number of subjects: 21
Study 26437830 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g freeze-dried wild blueberry (WBB) powder
Number of subjects: 21
Study 26437830 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 21
Study 24599458 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention (selective attention)
Number of subjects: 0
Study 22293570 — intervention group
Group type: EXPERIMENTAL
Intervention: Propionate-rich sourdough bread
Number of subjects: 20
Study 22293570 — intervention group
Group type: COMPARATOR
Intervention: Control bread
Number of subjects: 20
Study 20797593 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of a second LV lead (test group)
Number of subjects: 84
Study 20797593 — intervention group
Group type: COMPARATOR
Intervention: Standard biventricular stimulation (control group)
Number of subjects: 84
Study 17923591 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination ARB plus ACE inhibitor
Number of subjects: 17337
Study 16195984 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical swimming speed (CSS) at 92.7 +/- 2.6 % of maximal aerobic speed (MAS)
Number of subjects: 8
Study 16195984 — intervention group
Group type: COMPARATOR
Intervention: Speed at maximal lactate steady state (S (MLSS)) at 88.3 +/- 2.9 % of MAS
Number of subjects: 8
Study 11888584 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 560
Study 11888584 — intervention group
Group type: COMPARATOR
Intervention: Ciclosporin microemulsion
Number of subjects: 560
Study 9824351 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Cholangiopancreatography (MRCP)
Number of subjects: 60
Study 9824351 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic Retrograde Cholangiopancreatography (ERCP)
Number of subjects: 60
Study 8527688 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin (200 mg twice daily) + Ambroxol (30 mg thrice daily)
Number of subjects: 24
Study 8527688 — intervention group
Group type: COMPARATOR
Intervention: Ofloxacin (200 mg twice daily)
Number of subjects: 24
Study 2109531 — intervention group
Group type: EXPERIMENTAL
Intervention: rIFN‐gamma at 0.01 mg/m2
Number of subjects: 22
Study 2109531 — intervention group
Group type: EXPERIMENTAL
Intervention: rIFN‐gamma at 0.1 mg/m2
Number of subjects: 22
Study 2109531 — intervention group
Group type: EXPERIMENTAL
Intervention: rIFN‐gamma at three dose levels (0.01 mg/m2, 0.05 mg/m2, 0.1 mg/m2)
Number of subjects: 22
Study 2109531 — intervention group
Group type: EXPERIMENTAL
Intervention: rIFN‐gamma at 0.05 mg/m2 for 6 weeks
Number of subjects: 22
Study 7324924 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood tests measuring ASAT and CK levels
Number of subjects: 57
Study 7324924 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid tests measuring LD and HBD levels
Number of subjects: 57
Study 31409183 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 30
Study 31409183 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 30312135 — intervention group
Group type: EXPERIMENTAL
Intervention: Fucoidan 500 mg twice daily for 90 days
Number of subjects: 72
Study 30312135 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules twice daily for 90 days
Number of subjects: 72
Study 28369198 — intervention group
Group type: EXPERIMENTAL
Intervention: Seasonal inactivated influenza vaccine (IIV)
Number of subjects: 0
Study 28369198 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25899425 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine therapy
Number of subjects: 13
Study 24112444 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous endurance exercise in water
Number of subjects: 20
Study 24112444 — intervention group
Group type: COMPARATOR
Intervention: High intensity intermittent endurance exercise in water
Number of subjects: 20
Study 21857901 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA (4 mg i.m. by Biojector) at 0, 1 and 2 months, followed by rAd5 (10(10) PU i.m. by needle/syringe) at 6 months
Number of subjects: 480
Study 21857901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study 19394448 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise intervention for breast cancer survivors
Number of subjects: 413
Study 19394448 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 413
Study 20664352 — intervention group
Group type: EXPERIMENTAL
Intervention: Oesomeprazole 40 mg once daily for 7 days
Number of subjects: 78
Study 20664352 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 16313146 — intervention group
Group type: EXPERIMENTAL
Intervention: Active pressure-equalizing earplugs (JetEars)
Number of subjects: 27
Study 16313146 — intervention group
Group type: COMPARATOR
Intervention: Placebo earplugs
Number of subjects: 27
Study 12057730 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous endometrial coculture
Number of subjects: 208
Study 12057730 — intervention group
Group type: COMPARATOR
Intervention: Conventional media
Number of subjects: 208
Study 9857652 — intervention group
Group type: EXPERIMENTAL
Intervention: Procollagen III peptide concentration in bronchoalveolar lavage fluid in patients with allergic alveolitis
Number of subjects: 23
Study 9857652 — intervention group
Group type: EXPERIMENTAL
Intervention: Procollagen III peptide concentration in bronchoalveolar lavage fluid in patients with allergic alveolitis with DLCO < 60% pred
Number of subjects: 23
Study 9857652 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between BAL lymphocytes number and procollagen III peptide concentration
Number of subjects: 23
Study 9857652 — intervention group
Group type: COMPARATOR
Intervention: Procollagen III peptide concentration in bronchoalveolar lavage fluid in studied populations
Number of subjects: 23
Study 7503088 — intervention group
Group type: EXPERIMENTAL
Intervention: Suppressive doses of levothyroxine
Number of subjects: 0
Study 7503088 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation
Number of subjects: 0
Study 7503088 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioiodine, surgery, or ethanol injection for hot nodules
Number of subjects: 0
Study 7503088 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographically guided fine-needle aspiration for larger nodules (>1.5 cm)
Number of subjects: 0
Study 7503088 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitive thyrotropin assays
Number of subjects: 0
Study 7503088 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine-needle aspiration biopsy
Number of subjects: 0
Study 2152339 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate injected per anum (group 1, 19 patients)
Number of subjects: 36
Study 2152339 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate administered intravenously (group 2, 17 patients)
Number of subjects: 36
Study 349320 — intervention group
Group type: EXPERIMENTAL
Intervention: Elimination diet for four weeks
Number of subjects: 22
Study 349320 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined analysis of initial four-week diet period and four-week washout period
Number of subjects: 22
Study 349320 — intervention group
Group type: COMPARATOR
Intervention: Challenge with Yellow Dye No. 5 (tartrazine)
Number of subjects: 22
Study 349320 — intervention group
Group type: COMPARATOR
Intervention: Placebo challenge
Number of subjects: 22
Study 349320 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analysis of children on diet
Number of subjects: 22
Study 12160107 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.65 g alcohol/kg body weight)
Number of subjects: 102
Study 12160107 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 102
Study 12160107 — intervention group
Group type: COMPARATOR
Intervention: Water control
Number of subjects: 102
Study 31349723 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular aneurysm repair (EVAR)
Number of subjects: 78
Study 29249774 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle support program administered by pharmacists (brochures and healthy lifestyle advice using motivational interviewing methods) over a 12-week period
Number of subjects: 125
Study 29249774 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 125
Study 26500202 — intervention group
Group type: EXPERIMENTAL
Intervention: Task requiring self-control
Number of subjects: 111
Study 26500202 — intervention group
Group type: COMPARATOR
Intervention: Task not requiring self-control
Number of subjects: 111
Study 24928805 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa
Number of subjects: 1620
Study 24928805 — intervention group
Group type: EXPERIMENTAL
Intervention: MAOBI
Number of subjects: 1620
Study 24928805 — intervention group
Group type: COMPARATOR
Intervention: Dopamine agonists
Number of subjects: 1620
Study 22591999 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum IGF-I levels
Number of subjects: 776
Study 20205258 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent inactivated influenza vaccine
Number of subjects: 32
Study 19094535 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored surgery group (limited gastric resection with D0-D1 lymphadenectomy)
Number of subjects: 39
Study 19094535 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery group (standard radical gastrectomy with lymphadenectomy D2)
Number of subjects: 39
Study 15759083 — intervention group
Group type: EXPERIMENTAL
Intervention: UV-B broadband
Number of subjects: 110
Study 15759083 — intervention group
Group type: EXPERIMENTAL
Intervention: UV-B 311 nm narrowband
Number of subjects: 110
Study 15759083 — intervention group
Group type: COMPARATOR
Intervention: Comparison of UV-B broadband to UV-B 311 nm narrowband
Number of subjects: 110
Study 12375333 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily tramadol tablets
Number of subjects: 279
Study 12375333 — intervention group
Group type: COMPARATOR
Intervention: Normal release tramadol capsules (50 mg) taken 3 or 4 times daily
Number of subjects: 279
Study 9951568 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy (weekly interpersonal psychotherapy)
Number of subjects: 111
Study 9951568 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective sleep quality and REM activity measures
Number of subjects: 111
Study 7800322 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional transvaginal sonography
Number of subjects: 52
Study 7800322 — intervention group
Group type: EXPERIMENTAL
Intervention: Transabdominal sonohysterography
Number of subjects: 52
Study 7800322 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopy
Number of subjects: 52
Study 7800322 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonohysterographic evaluation
Number of subjects: 52
Study 7800322 — intervention group
Group type: COMPARATOR
Intervention: Hysteroscopy and transabdominal sonohysterography
Number of subjects: 52
Study 2189979 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily suction and débridement with intravenous mezlocillin
Number of subjects: 51
Study 2189979 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily suction and débridement with intravenous ceftazidime
Number of subjects: 51
Study 2189979 — intervention group
Group type: COMPARATOR
Intervention: Daily suction and débridement without antibiotics (control)
Number of subjects: 51
Study 2189979 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients treated initially with antibiotics
Number of subjects: 51
Study 2189979 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall recurrence rate
Number of subjects: 51
Study 25707 — intervention group
Group type: EXPERIMENTAL
Intervention: Tienilic acid (250 mg to 500 mg)
Number of subjects: 19
Study 25707 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (50 mg to 100 mg)
Number of subjects: 19
Study 25707 — intervention group
Group type: EXPERIMENTAL
Intervention: Tienilic acid
Number of subjects: 19
Study 25707 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 19
Study 25707 — intervention group
Group type: COMPARATOR
Intervention: Tienilic acid and Hydrochlorothiazide
Number of subjects: 19
Study 30431271 — intervention group
Group type: EXPERIMENTAL
Intervention: New strategy using residue type-specific dielectric constants and interaction entropy method
Number of subjects: 30
Study 30431271 — intervention group
Group type: COMPARATOR
Intervention: Standard MM/GBSA method with normal mode approach
Number of subjects: 30
Study 29967969 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin Sealant Grifols (FS Grifols)
Number of subjects: 325
Study 29967969 — intervention group
Group type: COMPARATOR
Intervention: Surgicel (oxidized cellulose sheets)
Number of subjects: 325
Study 26677829 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric overload training (ECC) group performed 6 weeks of eccentric overload training (twice weekly, 4 sets of 7 repetitions in a Yoyo squat device) before the running intervention.
Number of subjects: 20
Study 26677829 — intervention group
Group type: COMPARATOR
Intervention: Control group (CONT)
Number of subjects: 20
Study 24599421 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors
Number of subjects: 665
Study 24599421 — intervention group
Group type: COMPARATOR
Intervention: Selective estrogen-receptor modulators
Number of subjects: 665
Study 24599421 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 665
Study 24599421 — intervention group
Group type: EXPERIMENTAL
Intervention: Time elapsed since diagnosis
Number of subjects: 665
Study 24599421 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking at diagnosis
Number of subjects: 665
Study 24599421 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 665
Study 24599421 — intervention group
Group type: EXPERIMENTAL
Intervention: Hispanic ethnicity
Number of subjects: 665
Study 24599421 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight status at diagnosis
Number of subjects: 665
Study 24599421 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese status at diagnosis
Number of subjects: 665
Study 23363992 — intervention group
Group type: EXPERIMENTAL
Intervention: ZVF intervention (specifics not detailed in the abstract)
Number of subjects: 54
Study 23363992 — intervention group
Group type: EXPERIMENTAL
Intervention: Extrafoveal regions in AMD patients
Number of subjects: 54
Study 23363992 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast sensitivity
Number of subjects: 54
Study 23363992 — intervention group
Group type: EXPERIMENTAL
Intervention: Extrafoveal increment blue cone threshold
Number of subjects: 54
Study 20405093 — intervention group
Group type: EXPERIMENTAL
Intervention: STAR Workshop
Number of subjects: 0
Study 20405093 — intervention group
Group type: COMPARATOR
Intervention: Web-based, self-guided e-book
Number of subjects: 0
Study 20405093 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 0
Study 17628705 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction diathermy adenoidectomy
Number of subjects: 100
Study 17628705 — intervention group
Group type: COMPARATOR
Intervention: Curettage adenoidectomy
Number of subjects: 100
Study 17628705 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 100
Study 17628705 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction diathermy with tonsillectomy
Number of subjects: 100
Study 17628705 — intervention group
Group type: COMPARATOR
Intervention: Curettage with tonsillectomy
Number of subjects: 100
Study 16260662 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted surgery
Number of subjects: 60
Study 16260662 — intervention group
Group type: COMPARATOR
Intervention: Standard operation
Number of subjects: 60
Study 11829108 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) therapy
Number of subjects: 69
Study 11829108 — intervention group
Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 69
Study 9551752 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular advancement devices
Number of subjects: 15
Study 7528129 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blockers (general use)
Number of subjects: 0
Study 7528129 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blockers (late use)
Number of subjects: 0
Study 7528129 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blockers (heart failure)
Number of subjects: 0